language_icon
EN
HI

JB Chemicals & Pharmaceuticals Share price

JBCHEPHARM

2178.9

15.30 (0.71%)
NSE
BSE
Last updated on 21 May, 2026 | 15:56 IST
Today's High

2194.90

Today's Low

2154.50

52 Week Low

1603.50

52 Week High

2224.90

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

JB Chemicals & Pharmaceuticals Chart

JB Chemicals & Pharmaceuticals Share Key Metrics

Volume
4.18 L
Market Cap
34984.14 CR
LTQ@LTP
10@2178.90
ATP
2176.73
Var Margin
13.38 %
Circuit Range
1730.9-2596.3
Delivery %
61.98 %
Value
90.96 CR
ASM/GSM
No
Market Lot
1

Summary

JB Chemicals & Pharmaceuticals share price is ₹2178.9 as of 22 May, 2026. The stock JB Chemicals & Pharmaceuticals intraday movement has stayed between ₹2154.50 and ₹2194.90, while on a 52-week basis,JB Chemicals & Pharmaceuticals price 52 week high is ₹2224.90 & its 52 week low is ₹1603.50.
In terms of trading activity, JB Chemicals & Pharmaceuticals has recorded a volume of 417886 shares, The JB Chemicals & Pharmaceuticals has a market cap of ₹160558706 CR. The stock’s Average Traded Price (ATP) stands at ₹2176.73, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹2178.90.
JB Chemicals & Pharmaceuticals operates within a circuit range of ₹1730.90 – ₹2596.30, with a Value of ₹90.96 CR. The Delivery Percentage for the day is 61.98%. Additionally, JB Chemicals & Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

JB Chemicals & Pharmaceuticals Fundamentals

View More
P/E Ratio

48.89

P/B Ratio

8.34

Div. Yield

0.43

Sector P/E

71.81

Sector P/B

3.44

Sec. Div. Yield

0.55

JB Chemicals & Pharmaceuticals Resistance and Support

Pivot 2163.73

Resistance

First Resistance

2189.36

Second Resistance

2215.13

Third Resistance

2240.76

Support

First Support

2137.96

Second Support

2112.33

Third Support

2086.56

JB Chemicals & Pharmaceuticals Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

48.8%

Mutual Fund

19%

Insurance

1.33%

Foreign Institutional Investors

16.33%

Domestic Institutional Investors

1.05%

Retail

13.48%

Others

0.01%

Total Promoters
MAR '26
48.8%

JB Chemicals & Pharmaceuticals Corporate Actions

DateAgenda
2026-05-11Audited Results & Final Dividend
2026-02-05Interim Dividend
2026-01-16Quarterly Results
2025-11-11Quarterly Results
2025-07-30Quarterly Results
2025-05-14Audited Results & Final Dividend
2025-02-04Quarterly Results & Interim Dividend

JB Chemicals & Pharmaceuticals News

JB Chemicals & Pharmaceuticals Ltd - 506943 - Intimation Of Record Date

J B Chemicals fixed May 29, 2026 as record date for final dividend distribution. This determines shareholder eligibility for the dividend pertaining to financial year 2025-26.
May 21 2026 18:05:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

J B Chemicals held its Q4 FY26 earnings call, discussing an operational reset that impacted Q4 performance. Management expects normalization from Q1 FY27 and gradual recovery in both India and International businesses, with the merger process with Torrent Pharma in its final stages.
May 13 2026 14:05:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

J B Chemicals and Pharmaceuticals has made available the audio recording of its investors and analysts conference call for the fourth quarter ended March 31, 2026, on its website. This recording provides insights into the company's Q4 FY26 results and recent developments.
May 12 2026 14:05:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

J. B. Chemicals & Pharmaceuticals Limited disclosed it does not qualify as a 'Large Corporate' entity under the SEBI circular for fund raising via debt securities. This means the company is not subject to specific disclosure requirements applicable to such entities.
May 11 2026 23:05:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Corporate Action-Board approves Dividend

J.B. Chemicals Board recommended a final dividend of ₹9.30 per equity share for FY 2025-26. This 930% dividend on Re. 1 face value will be paid within 30 days of shareholder approval at the AGM.
May 11 2026 21:05:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

J.B. Chemicals reported Q4 FY26 revenue of Rs.904 cr, down 5% YoY, and net profit of Rs.101 cr, down 30% YoY. Full-year FY26 revenue grew 6% to Rs.4,148 cr.
May 11 2026 21:05:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Board Meeting Intimation for Meeting Of The Board Of Directors Will Be Held On May 11, 2026

J B Chemicals Board meeting scheduled for May 11, 2026. The agenda includes approval of standalone and consolidated audited financial results for Q4 FY26 and the full financial year, along with a recommendation for a final dividend for FY 2025-26.
May 05 2026 15:05:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

J B Chemicals & Pharmaceuticals' Equity Shareholders approved the Scheme of Amalgamation with Torrent Pharmaceuticals Limited. The resolution was passed via remote e-voting and e-voting at the NCLT convened meeting held on April 28, 2026.
Apr 28 2026 23:04:00
Read More

About JB Chemicals & Pharmaceuticals

NSE : 1726  
BSE : 506943  
ISIN : INE572A01036  

The Company was incorporated in December 1976 in the nameof J.B. Mody Chemicals and Pharmaceuticals Ltd. Later thename was changed to J.B. Chemical and Pharmaceuticals Ltd.and a fresh Certificate of Incorporation upon change ofname was issued on 21/08/85 by the Registrar of CompaniesMaharashtra at Mumbai.J.B. Chemicals and Pharmaceuticals Ltd. is the flagship ofthe ''Unique'' group of companies. The Company was foundedby Mr. J.B. Mody along with his two brothers Mr. D.B.Mody and Mr. S.B. Mody. It is engaged in the business ofmanufacturing bulk drugs intermediates formulationsayurvedic and herbal preparations. The Company''smanufacturing facilities are situated at Thane BelapurAnkleshwar Panoli and Daman. The product rangemanufactured at each of the plants is given below:------------------------------------------------------------Plant Year in which Products manufacturedSite set up / acquired------------------------------------------------------------Thane 1985 formulationsBelapur 1985 bulk drugs and intermediates.Ankleshwar 1985 bulk drugs intermediates formulations based on metroni- dazole and diclofenac sodium.Panoli 1992 soft gelatine capsules. 1994 liquid formulations. 1995 bulk drug plant to manufacture diclofenac sodium and intermediates.Daman 1995 cardiovascular formulations mainly in the form of tables and capsules and ayurvedic preparations.------------------------------------------------------------JBCPLs multi-locational multi-products plants enable it tocater to a large portion of the market. Today the Companyhas 46 products catering to 11 therapeutic segments. It isranked 37th in terms of domestic retail sales amongst thepharmaceutical companies in India (Source : ORG).

Read More

JB Chemicals & Pharmaceuticals Management

NamePosition
Sandeep PhadnisVice President- Secretarial & Company Secretary & Compliance Officer
Arun DuggalChairman
View More

JB Chemicals & Pharmaceuticals FAQs

The Buying Price of JB Chemicals & Pharmaceuticals share is 2178.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy JB Chemicals & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for JB Chemicals & Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of JB Chemicals & Pharmaceuticals shares is 48.89. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio JB Chemicals & Pharmaceuticals shares is 8.34. Useful to assess the stock's value relative to its book value.

To assess JB Chemicals & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 71.81 & 3.44 with sector averages, along with growth rates and financial metrics.

The Market Cap of JB Chemicals & Pharmaceuticals is 34984.14 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of JB Chemicals & Pharmaceuticals share price is 2224.90 & 1603.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

JB Chemicals & Pharmaceuticals belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost